Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression

24 Oct 2014

Abstract excerpt

// Linna Li 1, 6 , Chunping Liu 1 , Robert J. Amato 2 , Jeffrey T. Chang 3, 4 , Guangwei Du 3 , Wenliang Li 1, 2, 5 1 Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas 2 Division of Oncology, Department of Internal Medicine, and Memorial Hermann Cancer Center, University of Texas Health Science Center at Houston,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25333262
DOI: 10.18632/oncotarget.2535

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progressionPMID 25333262Read ↗

Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer MetastasisSemantic proximity Read ↗

Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impactSemantic proximity Read ↗

Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progressionSemantic proximity Read ↗

The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerSemantic proximity Read ↗

MAPKAPK2 (MK2) facilitates the epithelial-mesenchymal transition in lung adenocarcinoma through activation of the AKT/MYC signaling pathwaySemantic proximity Read ↗

RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMTSemantic proximity Read ↗

CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast CancerSemantic proximity Read ↗

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast CancerSemantic proximity Read ↗

Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cellsSemantic proximity Read ↗

Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncologySemantic proximity Read ↗

Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionSemantic proximity Read ↗

Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-likeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.